169 related articles for article (PubMed ID: 26341473)
1. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Kim HJ; Pandit A; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.
Kim HJ; Oh GS; Shen A; Lee SB; Choe SK; Kwon KB; Lee S; Seo KS; Kwak TH; Park R; So HS
Cell Death Dis; 2014 Jun; 5(6):e1292. PubMed ID: 24922076
[TBL] [Abstract][Full Text] [Related]
3. Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolism.
Pandit A; Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwon KB; Kwak TH; Choe SK; Park R; So HS
Biochem Biophys Res Commun; 2015 Nov; 467(4):697-703. PubMed ID: 26498527
[TBL] [Abstract][Full Text] [Related]
4. Modulation of NAD
Zhan T; Xiong H; Pang J; Zhang W; Ye Y; Liang Z; Huang X; He F; Jian B; He W; Gao Y; Min X; Zheng Y; Yang H
Toxicol Lett; 2021 Oct; 349():115-123. PubMed ID: 34089817
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Pandit A; Shim H; Yang SH; Cho EY; Song J; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2015 Aug; 326():30-9. PubMed ID: 25891352
[TBL] [Abstract][Full Text] [Related]
6. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Fang J; Wu H; Zhang J; Mao S; Shi H; Yu D; Chen Z; Su K; Xing Y; Dong H; Shi H
Biomed Pharmacother; 2022 Jun; 150():113071. PubMed ID: 35658237
[TBL] [Abstract][Full Text] [Related]
7. NAD
Shen A; Kim HJ; Oh GS; Lee SB; Lee SH; Pandit A; Khadka D; Choe SK; Kwak SC; Yang SH; Cho EY; Kim HS; Kim H; Park R; Kwak TH; So HS
Sci Rep; 2017 Jun; 7(1):3006. PubMed ID: 28592850
[TBL] [Abstract][Full Text] [Related]
8. Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD
Nazari Soltan Ahmad S; Rashtchizadeh N; Argani H; Roshangar L; Ghorbani Haghjo A; Sanajou D; Panah F; Ashrafi Jigheh Z; Dastmalchi S; Mesgari-Abbasi M
Free Radic Res; 2018 Jul; 52(7):808-817. PubMed ID: 29865885
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.
Oh GS; Kim HJ; Choi JH; Shen A; Choe SK; Karna A; Lee SH; Jo HJ; Yang SH; Kwak TH; Lee CH; Park R; So HS
Kidney Int; 2014 Mar; 85(3):547-60. PubMed ID: 24025646
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of NAD
Khadka D; Kim HJ; Oh GS; Shen A; Lee S; Lee SB; Sharma S; Kim SY; Pandit A; Choe SK; Kwak TH; Yang SH; Sim H; Eom GH; Park R; So HS
J Mol Cell Cardiol; 2018 Nov; 124():45-57. PubMed ID: 30291911
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Cellular NAD
Cao W; Zhu MY; Lee SH; Lee SB; Kim HJ; Park BO; Yoon CH; Khadka D; Oh GS; Shim H; Kwak TH; So HS
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769515
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
13. PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD
Zha S; Li Z; Cao Q; Wang F; Liu F
Stem Cell Res Ther; 2018 Aug; 9(1):224. PubMed ID: 30139380
[TBL] [Abstract][Full Text] [Related]
14. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity.
Caito S; Hwang JW; Chung S; Yao H; Sundar IK; Rahman I
Biochem Biophys Res Commun; 2010 Feb; 392(3):264-70. PubMed ID: 20060806
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
17. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
18. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
19. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Poljak A; Grant R
PLoS One; 2011 Apr; 6(4):e19194. PubMed ID: 21541336
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
